Rx Roundup: Quiz of the Week — April 12, 2024

This approval offers pediatric patients and caregivers the first subcutaneous option that can be administered at home.

Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

Alkaptonuria affects approximately 1 in 250,000 to 1 million people in the United States.

This study is the first to compare 2 biologics for patients with chronic rhinosinusitis with nasal polyps and coexisting asthma.

There were more fires in the span of a 13-year period from 2005 to 2018 than in the previous 2 decades.

The new approval is in line with recommendations that suggest booster vaccination for older adults and patients aged 12 to 64 with at least 1 or more underlying risk factors.